Pharmacogenetic studies in Alzheimer disease

Introduction: Alzheimer disease (AD) is the most common cause of dementia and is considered one of the main causes of disability and dependence affecting quality of life in elderly people and their families. Current pharmacological treatment includes acetylcholinesterase inhibitors (donepezil, galan...

Full description

Saved in:
Bibliographic Details
Main Authors: T. Zúñiga Santamaría, P. Yescas Gómez, I. Fricke Galindo, M. González González, A. Ortega Vázquez, M. López López
Format: Artigo
Language:Inglês
Published: Elsevier España 2022-05-01
Series:Neurología (English Edition)
Subjects:
Enfermedad de Alzheimer
Farmacogenética
Inhibidores de acetilcolinesterasa
APOE
CYP2D6
ABCB1
Online Access:http://www.sciencedirect.com/science/article/pii/S2173580820300882
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items